As of December 31, 2024, Purple Biotech (PPBT) had cash and cash equivalents and short-term deposits of $8.2 million, providing the Company a cash runway into mid-2026.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PPBT: